Fred E Cohen Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Fred E Cohen.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Fred E Cohen. Fred E Cohen is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in GENOMIC HEALTH INC ($GHDX) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CareDx, Inc. ($CDNA) and Director in VERACYTE, INC. ($VCYT) and Director in TANDEM DIABETES CARE INC ($TNDM) and Director in Roka BioScience, Inc. ($ROKA) and Director in Progyny, Inc. ($PGNY) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in UroGen Pharma Ltd. ($URGN).

Fred E Cohen in BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Fred E Cohen: Director
Holdings: 173,660 shares
Current Value: $984,652
Latest Transaction: Jun 22 2018
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Fred E Cohen in BIOCRYST PHARMACEUTICALS INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BCRX, CDNA, FPRX, GHDX, NTLA, PGNY, ROKA, TNDM, URGN, VCYT

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 22 2018	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	A	6.09	30,000	182,700	30,000
Sep 20 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	M	4.27	54,250	231,648	0
Sep 20 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Sell	S	5.42	54,250	294,035	119,410	173.7 K to 119.4 K (-31.24 %)
Sep 20 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Buy	M	4.27	54,250	231,648	173,660	119.4 K to 173.7 K (+45.43 %)
Jun 02 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	5.15	1,941	9,996	119,410	117.5 K to 119.4 K (+1.65 %)
May 25 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	A	5.13	30,000	153,900	30,000
Mar 02 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	6.24	1,602	9,996	117,469	115.9 K to 117.5 K (+1.38 %)
Dec 02 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	5.59	1,788	9,995	115,867	114.1 K to 115.9 K (+1.57 %)
Sep 06 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	4.11	2,433	10,000	114,079	111.6 K to 114.1 K (+2.18 %)
Jun 02 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	3.39	2,581	8,750	111,646	109.1 K to 111.6 K (+2.37 %)
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	A	3.22	30,000	96,600	30,000
Mar 01 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	1.99	4,396	8,748	109,065	104.7 K to 109.1 K (+4.20 %)
Dec 03 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	10.61	824	8,743	104,669	103.8 K to 104.7 K (+0.79 %)
Sep 02 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	11.64	751	8,742	103,845	103.1 K to 103.8 K (+0.73 %)
Jun 01 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	11.21	780	8,744	103,094	102.3 K to 103.1 K (+0.76 %)
May 22 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	A	11.39	15,000	170,850	15,000
Mar 03 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	10.20	857	8,741	102,314	101.5 K to 102.3 K (+0.84 %)

Page: 1